Contact

All Stories

  1. Evaluación del desempeño cognitivo en escolares y adolescentes con diabetes mellitus tipo 1.

    Article • Investigación Clínica, March 2023, Cuestiones Politicas, Universidad del Zulia

    Dr. Roberto Lanes

  2. Metabolic Syndrome as a Risk Factor for Sensorineural Hearing Loss in Adult Patients with Turner Syndrome

    Article • The Application of Clinical Genetics, January 2020, Taylor & Francis

    Dr. Roberto Lanes

  3. Anthropometric variables as cardiovascular risk predictors in a cohort of adult subjects with Turner syndrome

    Article • Diabetes Metabolic Syndrome and Obesity, September 2019, Taylor & Francis

    Dr Francisco Alvarez-Nava, Dr. Roberto Lanes, Jessica Guarderas, MARCIA RACINES

  4. Near Adult Height in Girls with Turner Syndrome Treated with Growth Hormone Following Either Induced or Spontaneous Puberty

    Article • The Journal of Pediatrics, September 2019, Elsevier

    Dr. Roberto Lanes

  5. Epigenetics in Turner syndrome

    Article • Clinical Epigenetics, April 2018, Springer Science + Business Media

    Dr. Roberto Lanes

  6. GH/IGF-1 Signaling and Current Knowledge of Epigenetics; a Review and Considerations on Possible Therapeutic Options

    Article • International Journal of Molecular Sciences, October 2017, MDPI AG

    Dr. Roberto Lanes

  7. Alternatives in the Treatment of Short Stature

    Article • Advances in Pediatrics, August 2017, Elsevier

    Dr. Roberto Lanes

  8. Cardiovascular Risk in Growth Hormone Deficiency

    Article • Endocrinology and Metabolism Clinics of North America, June 2016, Elsevier

    Dr. Roberto Lanes

  9. Metabolic Benefits of Growth Hormone Therapy

    Article • January 2016, Springer Science + Business Media

    Dr. Roberto Lanes

  10. Elevated second-trimester maternal serum β-human chorionic gonadotropin and amniotic fluid alpha-fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome

    Article • Journal of Obstetrics and Gynaecology Research, September 2015, Wiley

    Dr Francisco Alvarez-Nava, Dr. Roberto Lanes

  11. Higher prevalence of obesity and overweight without an adverse metabolic profile in girls with central precocious puberty compared to girls with early puberty, regardless of GnRH analogue treatment

    Article • International Journal of Pediatric Endocrinology, April 2014, Springer Science + Business Media

    Dr. Roberto Lanes

  12. Effect of the parental origin of the X-chromosome on the clinical features, associated complications, the two-year-response to growth hormone (rhGH) and the biochemical profile in patients with turner syndrome

    Article • International Journal of Pediatric Endocrinology, June 2013, Springer Science + Business Media

    Dr. Roberto Lanes

  13. Consenso Latinoamericano: niños pequeños para la edad gestacional

    Article • Revista chilena de pediatría, December 2012, Sociedad Chilena de Pediatria

    Dr. Roberto Lanes

  14. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2012, De Gruyter

    Dr. Roberto Lanes

  15. Latin American Consensus: Children Born Small for Gestational Age

    Article • BMC Pediatrics, July 2011, Springer Science + Business Media

    Dr. Roberto Lanes

  16. Sex hormone priming

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2011, De Gruyter

    Dr. Roberto Lanes

  17. Limited Weight Loss or Simply No Weight Gain following Lifestyle-Only Intervention Tends to Redistribute Body Fat, to Decrease Lipid Concentrations, and to Improve Parameters of Insulin Sensitivity in Obese Children

    Article • International Journal of Pediatric Endocrinology, January 2011, Springer Science + Business Media

    Dr. Roberto Lanes

  18. Maintenance of Weight or Modest Weight Loss Following Lifestyle-Only Intervention Tends To Redistribute Body Fat, Decrease Lipid, CRP and Fibrinogen Levels and To Improve Parameters of Insulin Sensitivity in Obese Children.

    Article • June 2010, Endocrine Society

    Dr. Roberto Lanes

  19. Growth Hormone Deficiency: Transition from Adolescence to Adulthood. Highlights from a Latin-American Serono Symposia International Foundation Conference

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2010, De Gruyter

    PROF CESAR L BOGUSZEWSKI, Dr. Roberto Lanes

  20. GHR and VDR Genes do not Contribute to the Growth Hormone (GH) Response in GH Deficient and Turner Syndrome Patients

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2010, De Gruyter

    Dr. Roberto Lanes

  21. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors

    Article • Pediatric Diabetes, October 2008, Wiley

    Dr. Roberto Lanes

  22. Turner syndrome patients with a ring X chromosome

    Article • Clinical Genetics, April 2008, Wiley

    Dr. Roberto Lanes

  23. Circulating Levels of High-Sensitivity C-Reactive Protein and Soluble Markers of Vascular Endothelial Cell Activation in Growth Hormone-Deficient Adolescents

    Article • Hormone Research, January 2008, Karger Publishers

    Dr. Roberto Lanes

  24. Endothelial Dysfunction in Growth Hormone Deficiency

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2008, De Gruyter

    Dr. Roberto Lanes

  25. Is Testosterone and Estrogen Priming Prior to Clonidine Useful in the Evaluation of the Growth Hormone Status of Short Peripubertal Children?

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2008, De Gruyter

    Dr. Roberto Lanes

  26. A GnRH analog test in diagnosing gonadotropin deficiency in males with delayed puberty

    Article • The Journal of Pediatrics, November 2006, Elsevier

    Dr. Roberto Lanes

  27. Coronary artery calcification, serum lipids, lipoproteins, and peripheral inflammatory markers in adolescents and young adults with type 1 diabetes

    Article • The Journal of Pediatrics, September 2006, Elsevier

    Dr. Roberto Lanes

  28. Growth hormone deficiency, low levels of adiponectin, and unfavorable plasma lipid and lipoproteins

    Article • The Journal of Pediatrics, September 2006, Elsevier

    Dr. Roberto Lanes

  29. Relationship Between Different Fasting-Based Insulin Sensitivity Indices in Obese Children and Adolescents

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2006, De Gruyter

    Dr. Roberto Lanes

  30. Endothelial Function, Carotid Artery Intima-Media Thickness, Epicardial Adipose Tissue, and Left Ventricular Mass and Function in Growth Hormone-Deficient Adolescents: Apparent Effects of Growth Hormone Treatment on These Parameters

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2005, Endocrine Society

    Dr. Roberto Lanes

  31. Leptina en relación con el sexo, el índice de masa corporal, el estadio puberal y la insulina en niños con déficit de hormonas de crecimiento con y sin tratamiento sustitutivo

    Article • Endocrinología y Nutrición, July 2005, Elsevier

    Dr. Roberto Lanes

  32. Peripheral inflammatory and fibrinolytic markers in adolescents with growth hormone deficiency: Relation to postprandial dyslipidemia

    Article • The Journal of Pediatrics, November 2004, Elsevier

    Dr. Roberto Lanes

  33. Decreased final height of children with growth deceleration secondary to poor weight gain during late childhood

    Article • The Journal of Pediatrics, July 2004, Elsevier

    Dr. Roberto Lanes

  34. Accelerated Versus Slowly Progressive Forms of Puberty in Girls with Precocious and Early Puberty. Gonadotropin Suppressive Effect and Final Height Obtained with Two Different Analogs

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2004, De Gruyter

    Dr. Roberto Lanes

  35. Female Pseudohermaphroditism with Phallic Urethra in the Offspring of a Mother with an Adrenal Tumor

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2004, De Gruyter

    Dr. Roberto Lanes

  36. Long-Term Outcome of Growth Hormone Therapy in Children and Adolescents

    Article • Treatments in Endocrinology, January 2004, Springer Science + Business Media

    Dr. Roberto Lanes

  37. Molecular analysis in Turner syndrome

    Article • The Journal of Pediatrics, March 2003, Elsevier

    Dr. Roberto Lanes

  38. Cardiovascular Risk of Young Growth-Hormone-Deficient Adolescents

    Article • Hormone Research in Paediatrics, January 2003, Karger Publishers

    Dr. Roberto Lanes

  39. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study

    Article • Clinical Endocrinology, December 2002, Wiley

    Dr. Roberto Lanes

  40. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?

    Article • The Journal of Pediatrics, November 2002, Elsevier

    Dr. Roberto Lanes

  41. Cardiac Mass and Function, Carotid Artery Intima-Media Thickness, and Lipoprotein Levels in Growth Hormone-Deficient Adolescents

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2001, Endocrine Society

    Dr. Roberto Lanes

  42. Cardiac Mass and Function, Carotid Artery Intima-Media Thickness, and Lipoprotein Levels in Growth Hormone-Deficient Adolescents

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2001, Endocrine Society

    Dr. Roberto Lanes

  43. Final Adult Height in Short Healthy Children Treated with Growth Hormone and Gonadotropin-Releasing Hormone Analogs

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2001, Endocrine Society

    Dr. Roberto Lanes

  44. Decreased Bone Mineral Density and Bone Formation Markers Shortly After Diagnosis of Clinical Type 1 Diabetes Mellitus

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2001, De Gruyter

    Dr. Roberto Lanes

  45. Bone mineral density and Turner’s syndrome—any lessons to be learned about “menopausal osteoporosis”: commentary

    Article • Fertility and Sterility, October 2000, Elsevier

    Dr. Roberto Lanes

  46. Bone mineral density and Turner’s syndrome—any lessons to be learned about “menopausal osteoporosis”: the reply

    Article • Fertility and Sterility, October 2000, Elsevier

    Dr. Roberto Lanes

  47. Growth Velocity, Final Height and Bone Mineral Metabolism of Short Children Treated Long Term with Growth Hormone

    Article • Current Pharmaceutical Biotechnology, July 2000, Bentham Science Publishers

    Dr. Roberto Lanes

  48. Growth Hormone Treatment in Patients with Intrauterine Growth Retardation

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2000, Endocrine Society

    Dr. Roberto Lanes

  49. Circulating Iodide Concentrations during and after Pregnancy

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2000, Endocrine Society

    Dr. Roberto Lanes

  50. Growth Hormone Treatment in Patients with Intrauterine Growth Retardation

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2000, Endocrine Society

    Dr. Roberto Lanes

  51. Acipimox, a Nicotinic Acid Analog, Stimulates Growth Hormone Secretion in Short Healthy Prepubertal Children

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2000, De Gruyter

    Dr. Roberto Lanes

  52. Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner’s syndrome and previously normal bone density

    Article • Fertility and Sterility, November 1999, Elsevier

    Dr. Roberto Lanes

  53. Decreased trabecular bone mineral density in children with idiopathic short stature: Normalization of bone density and increased bone turnover after 1 year of growth hormone treatment

    Article • The Journal of Pediatrics, August 1999, Elsevier

    Dr. Roberto Lanes

  54. Bone, chronic renal failure and GH treatment

    Article • Clinical Endocrinology, July 1999, Wiley

    Dr. Roberto Lanes

  55. Decreased Trabecular Bone Mineral Density in Children with Idiopathic Short Stature. Normalization of Bone Density and Increased Bone Turnover after One Year of Growth Hormone Treatment

    Article • Pediatric Research, April 1999, Springer Science + Business Media

    Dr. Roberto Lanes

  56. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty

    Article • Clinical Endocrinology, August 1998, Wiley

    Dr. Roberto Lanes

  57. Final height after combined growth hormone and gonadotropin-releasing hormone analog therapy in short healthy children entering into normally time puberty

    Article • Growth Hormone & IGF Research, August 1998, Elsevier

    Dr. Roberto Lanes

  58. Decreased Bone Mineral Densities (BMD) and Bone Formation Markers During the First Year After Diagnosis of Insulin Dependent Diabetes Mellitus (IDDM) in Children. 431

    Article • Pediatric Research, April 1998, Springer Science + Business Media

    Dr. Roberto Lanes

  59. Decreased Lumbar Spine Bone Mass and Low Bone Turnover in Children and Adolescents with Insulin Dependent Diabetes Mellitus Followed Longitudinally

    Article • Journal of Pediatric Endocrinology and Metabolism, January 1998, De Gruyter

    Dr. Roberto Lanes

  60. Serum lipids, lipoprotein Ip(a), and plasminogen activator inhibitor-1 in patients with Turner's syndrome before and during growth hormone and estrogen therapy

    Article • Fertility and Sterility, September 1997, Elsevier

    Dr. Roberto Lanes

  61. Effectiveness and Limitations of the Use of the Gonadotropin-Releasing Hormone Agonist Leuprolide Acetate in the Diagnosis of Delayed Puberty in Males

    Article • Hormone Research, January 1997, Karger Publishers

    Dr. Roberto Lanes

  62. Changes in Bone Mineral Density, Growth Velocity and Renal Function of Prepubertal Uremic Children during Growth Hormone Treatment

    Article • Hormone Research, January 1996, Karger Publishers

    Dr. Roberto Lanes

  63. Effect of Glycemic Control on the Growth Velocity and Several Metabolic Parameters of Conventionally Treated Children with Insulin Dependent Diabetes Mellitus

    Article • Journal of Pediatric Endocrinology and Metabolism, January 1996, De Gruyter

    Dr. Roberto Lanes

  64. EPIDEMIOLOGY AND IMMUNOGENETICS OF INSULIN-DEPENDENT DIABETES MELLITUS IN VENEZUELAN CHILDREN

    Article • Pediatric Research, October 1995, Springer Science + Business Media

    Dr. Roberto Lanes

  65. Short- and long-term effect of oral salbutamol on growth hormone secretion in prepubertal asthmatic children

    Article • Metabolism, February 1995, Elsevier

    Dr. Roberto Lanes

  66. Bone Mineral Density of Prepubertal Age Girls with Turner’s Syndrome While on Growth Hormone Therapy

    Article • Hormone Research, January 1995, Karger Publishers

    Dr. Roberto Lanes

  67. Effects of Two Years of Growth Hormone Treatment in Short, Slowly Growing Non-Growth Hormone Deficient Children

    Article • Journal of Pediatric Endocrinology and Metabolism, January 1995, De Gruyter

    Dr. Roberto Lanes

  68. HLA-DQA1 AND DQB 1 ALLELE AND GENOTYPE CONTRIBUTION TO IDDM SUSCEPTIBILITY IN AN ETHNICALLY MIXED POPULATION

    Article • European Journal of Immunogenetics, December 1994, Wiley

    Dr. Roberto Lanes

  69. Long Term Therapy with a Single Daily Subcutaneous Dose of Growth Hormone Releasing Hormone (1-29) in Prepubertal Growth Hormone Deficient Children

    Article • Journal of Pediatric Endocrinology and Metabolism, January 1994, De Gruyter

    Dr. Roberto Lanes

  70. CHANGES IN BONE MINERAL, CONTENT (BMC) IN PREPUBERTAL, CHILDREN WITH MARKED SHORT STATHRE SECONDARY TO CHRONIC RENAL FAILURE (CRF): EFFECTS OF rhGH THERAPY

    Article • Pediatric Research, May 1993, Springer Science + Business Media

    Dr. Roberto Lanes

  71. Sustained improvement in growth velocity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH-releasing hormone-(1-44)-NH2.

    Article • The Journal of Clinical Endocrinology & Metabolism, November 1992, Endocrine Society

    Dr. Roberto Lanes

  72. Growth hormone therapy in a poorly growing child with hypophosphatemic rickets

    Article • Journal of Endocrinological Investigation, November 1990, Springer Science + Business Media

    Dr. Roberto Lanes

  73. ACTH Stimulation Tests and Plasma Dehydroepiandrosterone Sulfate Levels in Women with Hirsutism

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 1990, New England Journal of Medicine (NEJM/MMS)

    Dr. Roberto Lanes

  74. Growth Hormone Secretion in Pubertal Age Patients with Turner's Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1990, Endocrine Society

    Dr. Roberto Lanes

  75. Diagnostic Limitations of Spontaneous Growth Hormone Measurements in Normally Growing Prepubertal Children

    Article • Archives of Pediatrics and Adolescent Medicine, November 1989, American Medical Association (AMA)

    Dr. Roberto Lanes

  76. The metoclopramide test: a useful tool with the luteinizing hormone-releasing hormone test in distinguishing between constitutional delay of puberty and hypogonadotropic hypogonadism

    Article • Fertility and Sterility, July 1989, Elsevier

    Dr. Roberto Lanes

  77. Growth Hormone Release in Response to Growth Hormone-Releasing Hormone in Term and Preterm Neonates

    Article • Neonatology, January 1989, Karger Publishers

    Dr. Roberto Lanes

  78. 6.1-05 HLA haplotypes in IDDM patients of mixed ethnic origin

    Article • Human Immunology, January 1989, Elsevier

    Dr. Roberto Lanes

  79. Glycemic response in children with insulin-dependent diabetes mellitus after high- or low-glycemic-index breakfast

    Article • American Journal of Clinical Nutrition, November 1987, Oxford University Press (OUP)

    Dr. Roberto Lanes

  80. HCG Stimulation in Children With Cryptorchidism

    Article • Clinical Pediatrics, October 1987, SAGE Publications

    Dr. Roberto Lanes

  81. Premarin priming does not alter growth hormone release following exercise

    Article • Journal of Endocrinological Investigation, December 1986, Springer Science + Business Media

    Dr. Roberto Lanes

  82. Growth hormone secretion in patients with constitutional delay of growth and pubertal development

    Article • The Journal of Pediatrics, November 1986, Elsevier

    Dr. Roberto Lanes

  83. Evaluation of the pituitary-thyroidal axis in newborns undergoing exchange transfusion

    Article • European Journal of Pediatrics, April 1986, Springer Science + Business Media

    Dr. Roberto Lanes

  84. Breast feeding and insulin-dependent diabetes mellitus in children.

    Article • Journal of the American College of Nutrition, January 1986, Taylor & Francis

    Dr. Roberto Lanes

  85. Effect of Asphyxia on Free Thyroid Hormone Levels in Full Term Newborns

    Article • Pediatric Research, December 1985, Springer Science + Business Media

    Dr. Roberto Lanes

  86. 483 PITUITARY FUNCTION IN PRIMARY MALNUTRITION DUE TO ANOREXIA NERVOSA AND OTHER EATING DISORDERS

    Article • Pediatric Research, April 1985, Springer Science + Business Media

    Dr. Roberto Lanes

  87. Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus

    Article • Diabetes, February 1985, American Diabetes Association

    Dr. Roberto Lanes

  88. Impaired Somatomedin Generation Test in Children with Insulin-dependent Diabetes Mellitus

    Article • Diabetes, February 1985, American Diabetes Association

    Dr. Roberto Lanes

  89. Cortisol Levels and Clonidine Administration

    Article • Archives of Pediatrics and Adolescent Medicine, January 1985, American Medical Association (AMA)

    Dr. Roberto Lanes

  90. Low-Dose Oral Clonidine

    Article • American Journal of Diseases of Children, January 1985, American Medical Association (AMA)

    Dr. Roberto Lanes

  91. A Clinical Syndrome of Mild Androgen Insensitivity*

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1984, Endocrine Society

    Dr. Roberto Lanes

  92. Abnormalities of thyroid function in infants with Down syndrome

    Article • The Journal of Pediatrics, April 1984, Elsevier

    Dr. Roberto Lanes

  93. IMPAIRED SOMATOMEDIN (SM) GENERATION TEST IN POORLY CONTROLLED INSULIN DEPEDENT DIABETES MELLIITUS (IDDM)

    Article • Pediatric Research, April 1984, Springer Science + Business Media

    Dr. Roberto Lanes

  94. LOW DOSE ORAL CLONIDINE: A SIMPLE AND RELIABLE GROWTH HORMONE (GH) SCREENING TEST

    Article • Pediatric Research, April 1984, Springer Science + Business Media

    Dr. Roberto Lanes

  95. Clonidine is a better test of growth hormone deficiency

    Article • Archives of Disease in Childhood, September 1983, BMJ

    Dr. Roberto Lanes

  96. Reply

    Article • The Journal of Pediatrics, September 1983, Elsevier

    Dr. Roberto Lanes

  97. Sibship with 17-Ketosteroid Reductase (17-KSR) Deficiency and Hypothyroidism. Lack of Linkage of Histocompatibility Leucocyte Antigen and 17-KSR Loci*

    Article • The Journal of Clinical Endocrinology & Metabolism, July 1983, Endocrine Society

    Dr. Roberto Lanes

  98. Decreased secretion of cortisol and ACTH after oral clonidine administration in normal adults

    Article • Metabolism, June 1983, Elsevier

    Dr. Roberto Lanes

  99. Reply

    Article • The Journal of Pediatrics, March 1983, Elsevier

    Dr. Roberto Lanes

  100. Calcitonin and calcium therapy in an infant with osteogenesis imperfecta congenita.

    Article • Journal of the American College of Nutrition, January 1983, Taylor & Francis

    Dr. Roberto Lanes

  101. Oral clonidine — an effective growth hormone-releasing agent in prepubertal subjects

    Article • The Journal of Pediatrics, May 1982, Elsevier

    Dr. Roberto Lanes

  102. Adrenal Cortical Carcinoma in a 4-Year-Old Child

    Article • Clinical Pediatrics, March 1982, SAGE Publications

    Dr. Roberto Lanes

  103. Dwarfism Associated with Normal Serum Growth Hormone and Increased Bioassayable, Receptorassayable, and Immunoassayable Somatomedin

    Article • The Journal of Clinical Endocrinology & Metabolism, March 1980, Endocrine Society

    Dr. Roberto Lanes

  104. Glucocorticoid and Partial Mineralocorticoid Deficiency Associated with Achalasia*

    Article • The Journal of Clinical Endocrinology & Metabolism, February 1980, Endocrine Society

    Dr. Roberto Lanes

  105. Are Constitutional Delay of Growth and Familial Short Stature Different Conditions?

    Article • Clinical Pediatrics, January 1980, SAGE Publications

    Dr. Roberto Lanes

  106. Persistence of the enzymatic block in adolescent patients with salt-losing congenital adrenal hyperplasia

    Article • The Journal of Pediatrics, October 1979, Elsevier

    Dr. Roberto Lanes

  107. Sustained Effect of Human Growth Hormone Therapy on Children With Intrauterine Growth Retardation

    Article • PEDIATRICS, May 1979, American Academy of Pediatrics (AAP)

    Dr. Roberto Lanes

  108. Evaluation of the Growth Hormone Exercise Test in Normal and Growth Hormone-Deficient Children

    Article • PEDIATRICS, October 1978, American Academy of Pediatrics (AAP)

    Dr. Roberto Lanes

  109. Congenital Hypopituitarism and Conjugated Hyperbilirubinemia in Two Infants

    Article • Archives of Pediatrics and Adolescent Medicine, September 1978, American Medical Association (AMA)

    Dr. Roberto Lanes

  110. 309 SUSTAINED EFFECT OF HUMAN GROWTH HORMONE (hGH) THERAPY ON CHILDREN WITH INTRAUTERINE GROWTH RETARDATION (IUGR)

    Article • Pediatric Research, April 1978, Springer Science + Business Media

    Dr. Roberto Lanes